Clinical assessment of the miR-34, miR-200, ZEB1 and SNAIL EMT regulation hub underlines the differential prognostic value of EMT miRs to drive mesenchymal transition and prognosis in resected NSCLC.
Simon GarinetAudrey DidelotThomas DenizeAlexandre PerrierGuillaume BeinseJean-Baptiste LeclereJean-Baptiste OudartLaure GibaultCecile BadoualFrançoise Le Pimpec-BarthesPierre Laurent-PuigAntoine LegrasHelene BlonsPublished in: British journal of cancer (2021)
miR-200 family members do not have similar predictive value. Core EMT-miR, regulators and not EMT itself, identify NSCLC patients with a low risk of relapse after surgery.